Universal stock kpis
Want to see UVV full AI Analyst Report?
Revenue by Segment
Universal reported revenue by segment of $621.85M in Q2 FY2027, up 18.7% from Q1 FY2027 and down 17.5% year over year. The highest value was $937.19M in Q3 FY2025.
Breaks down sales across the company’s business units to show which segments drive growth and which are lagging; reveals dependence on particular products, regions, or customers and highlights where management is focusing expansion or where revenue risk is concentrated.
Tobacco is clearly the cash engine—steady, seasonal revenue strength is masking margin stress from rising inventory and repeat write‑downs; management’s pledge to cut uncommitted inventory to 10–20% is the critical near‑term lever to protect profits. Ingredients shows modest revenue growth but shrinking profitability, with Shanks’ execution problems culminating in a goodwill impairment; the investment case now rests less on topline expansion and more on inventory discipline and a successful operational turnaround at Shanks to restore margins and free cash flow.
UVV Revenue by Segment
| Period | Tobacco Operations | Ingredients Operations | Total |
|---|---|---|---|
| Q2 FY2027Sep 30, 2026 | $534.34M | $87.50M | $621.85M |
| Q1 FY2027Jun 30, 2026 | $437.13M | $86.65M | $523.78M |
| Q4 FY2026Mar 31, 2026 | $632.29M | $82.95M | $715.24M |
| Q3 FY2026Dec 31, 2025 | $779.95M | $81.34M | $861.29M |
| Q2 FY2026Sep 30, 2025 | $659.42M | $94.75M | $754.18M |
| Q1 FY2026Jun 30, 2025 | $504.70M | $89.07M | $593.76M |
| Q4 FY2025Mar 31, 2025 | $612.62M | $89.66M | $702.28M |
| Q3 FY2025Dec 31, 2024 | $853.88M | $83.31M | $937.19M |
| Q2 FY2025Sep 30, 2024 | $630.21M | $80.55M | $710.76M |
| Q1 FY2025Jun 30, 2024 | $511.95M | $85.09M | $597.05M |
| Q4 FY2024Mar 31, 2024 | $696.28M | $74.58M | $770.86M |
| Q3 FY2024Dec 31, 2023 | $743.93M | $77.57M | $821.51M |
| Q2 FY2024Sep 30, 2023 | $554.65M | $83.83M | $638.48M |
| Q1 FY2024Jun 30, 2023 | $443.91M | $73.81M | $517.72M |
| Q4 FY2023Mar 31, 2023 | $615.58M | $78.40M | $693.98M |
| Q3 FY2023Dec 31, 2022 | $724.59M | $70.45M | $795.04M |
| Q2 FY2023Sep 30, 2022 | $570.03M | $80.95M | $650.98M |
| Q1 FY2023Jun 30, 2022 | $348.06M | $81.76M | $429.82M |
| Q4 FY2022Mar 31, 2022 | $567.18M | $79.79M | $646.97M |
| Q3 FY2022Dec 31, 2021 | $578.00M | $74.64M | $652.64M |
| Q2 FY2022Sep 30, 2021 | $396.76M | $57.19M | $453.95M |
| Q1 FY2022Jun 30, 2021 | $293.84M | $56.19M | $350.03M |

